Consolidated Portfolio Review Corp’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio BCAT Stock Details BCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,690	Closed	-$188K	–	66
2025 Q3	$188K	Sell	12,690 -5,780	-31%	-$86.5K	0.02%	441
2025 Q2	$280K	Sell	18,470 -10,298	-36%	-$150K	0.04%	367
2025 Q1	$414K	Sell	28,768 -6,579	-19%	-$101K	0.07%	250
2024 Q4	$536K	Hold	35,347	–	–	0.08%	220
2024 Q3	$581K	Sell	35,347 -934	-3%	-$15.3K	0.13%	175
2024 Q2	$595K	Sell	36,281 -49,587	-58%	-$797K	0.14%	169
2024 Q1	$1.43M	Sell	85,868 -3,754	-4%	-$58.2K	0.38%	74
2023 Q4	$1.34M	Buy	89,622 +2,017	+2%	+$29.3K	0.31%	90
2023 Q3	$1.27M	Sell	87,605 -8,751	-9%	-$131K	0.31%	88
2023 Q2	$1.47M	Sell	96,356 -7,441	-7%	-$112K	0.35%	82
2023 Q1	$1.57M	Buy	+103,797	New	+$1.54M	0.43%	63

Other funds holding BCAT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Consolidated Portfolio Review Corp's BCAT Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q4 2025, closing a stake of 12,690 shares — an estimated $188K sold.

Consolidated Portfolio Review Corp first reported a position in BCAT in Q1 2023 and held it in 11 quarters. The position peaked at $1.57M in Q1 2023. 106 funds tracked by Wall St. Rank hold BCAT as of Q4 2025.

Consolidated Portfolio Review Corp reported no remaining BlackRock Capital Allocation Term Trust position as of Q4 2025 after selling out during the quarter.
Consolidated Portfolio Review Corp sold 12,690 BlackRock Capital Allocation Term Trust shares in Q4 2025, an estimated $188K.
Consolidated Portfolio Review Corp first reported a position in BlackRock Capital Allocation Term Trust in Q1 2023 and held it in 11 quarters.
Consolidated Portfolio Review Corp's BlackRock Capital Allocation Term Trust position peaked at $1.57M in Q1 2023.
106 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.